Deucravacitinib, CAS [[1609392-27-9]]

Product Overview

• Article Name: Deucravacitinib, CAS [[1609392-27-9]]
• Biozol Catalog Number: MCE-HY-117287
• Supplier Catalog Number: HY-117287
• Alternative Catalog Number: MCE-HY-117287-1G,MCE-HY-117287-10MG,MCE-HY-117287-10MMX1ML,MCE-HY-117287-2MG,MCE-HY-117287-50MG,MCE-HY-117287-5MG,MCE-HY-117287-200MG,MCE-HY-117287-100MG,MCE-HY-117287-25MG,MCE-HY-117287-500MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: BMS-986165

Product Description

Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases, which selectively binds to TYK2 pseudokinase (JH2) domain (IC50=1.0 nM) and blocks receptor-mediated Tyk2 activation by stabilizing the regulatory JH2 domain. Deucravacitinib inhibits IL-12/23 and type I IFN pathways. Deucravacitinib, the FDAs world first de novo deuterium, is available for study in moderate to severe plaque psoriasis[1][2].

Product Properties

• Molecular Weight: 425.46
• Purity: 99.93
• CAS Number: [1609392-27-9]
• Formula: C20H19D3N8O3
• Target: IFNAR,Interleukin Related,Isotope-Labeled Compounds,JAK

Application Notes

• Application Notes: MCE Product type: Isotope-Labeled Compounds